sepsis

sepsis
Emergency doc · CC BY-SA 4.0 · source
Name	Sepsis
Field	Infectious disease, Intensive care medicine

sepsis

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. It intersects with major figures and institutions in global health, from Alexander Fleming and the discovery of antibiotics to the modern work of the World Health Organization and the Centers for Disease Control and Prevention. Recognition and management draw on guidelines from bodies such as the Surviving Sepsis Campaign, and clinical practice in settings like Johns Hopkins Hospital and Mayo Clinic.

Definition and Epidemiology

Sepsis is defined clinically by organ dysfunction attributable to infection and widespread host inflammatory responses. Epidemiological estimates rely on datasets and reporting frameworks maintained by World Health Organization, Global Burden of Disease Study, and national agencies such as the National Health Service (England), Centers for Disease Control and Prevention, and European Centre for Disease Prevention and Control. Incidence varies by region, with higher rates reported in low- and middle-income countries and in demographic groups served by institutions like Médecins Sans Frontières and The Bill & Melinda Gates Foundation-funded programs. Major population studies from Oxford University and Harvard University provide data on age distribution, showing peak vulnerability in neonates, older adults, and immunocompromised patients treated at centers such as Cleveland Clinic.

Pathophysiology

Sepsis involves pathogen-host interactions leading to dysregulated immune, coagulation, metabolic, and endothelial responses. Research from laboratories affiliated with Pasteur Institute, Max Planck Society, and National Institutes of Health has elucidated roles for cytokine cascades, complement activation, and mitochondrial dysfunction. The interplay between proinflammatory mediators (studied at Johns Hopkins University and Imperial College London) and immunosuppressive phases (investigated at Stanford University and UCSF Medical Center) explains heterogeneity in clinical trajectories. Microcirculatory failure, described in work linked to Karolinska Institutet and University of Toronto, contributes to organ hypoperfusion and failure. Coagulation abnormalities in sepsis echo findings from Royal College of Physicians-affiliated research on disseminated intravascular coagulation.

Causes and Risk Factors

Bacterial infections are the most common triggers, with pathogens such as Staphylococcus aureus and Escherichia coli often implicated in datasets compiled by Public Health England and the European Medicines Agency. Viral and fungal causes, examined during outbreaks investigated by Centers for Disease Control and Prevention and World Health Organization, include agents studied in the context of Ebola virus epidemic and Candida surveillance at institutions like Johns Hopkins Hospital. Risk factors identified in cohort studies from Mayo Clinic, Mount Sinai Hospital, and Karolinska Universitetssjukhuset include advanced age, comorbidities tracked in registries at Massachusetts General Hospital, immunosuppression from treatments at MD Anderson Cancer Center, and invasive procedures performed in tertiary centers like Royal London Hospital. Socioeconomic and geographic disparities reported by The Lancet and BMJ connect higher sepsis burden to regions served by Doctors Without Borders and constrained public health infrastructure.

Clinical Presentation and Diagnosis

Clinical recognition relies on signs of infection plus organ dysfunction, with bedside tools and criteria developed collaboratively by experts from Society of Critical Care Medicine and the European Society of Intensive Care Medicine. Common presentations include altered mental status documented in case series from Charité – Universitätsmedizin Berlin, hypotension studied at University College London Hospitals, and respiratory failure as reported in cohorts from Bellevue Hospital and Addenbrooke's Hospital. Diagnostic work-up involves microbiological cultures performed in laboratories accredited by College of American Pathologists and imaging modalities available at centers like Johns Hopkins Hospital. Biomarkers such as lactate and procalcitonin have been evaluated in trials at Vanderbilt University Medical Center and University of Pittsburgh Medical Center. Sepsis bundles and early warning scores are implemented across systems including NHS England and Veterans Health Administration to improve recognition.

Management and Treatment

Management principles combine early source control, antimicrobial therapy, hemodynamic support, and organ support in intensive care units within networks like Surviving Sepsis Campaign hospitals. Early broad-spectrum antibiotics are guided by stewardship programs at Infectious Diseases Society of America-affiliated centers and tailored using susceptibility data from Clinical and Laboratory Standards Institute and regional public health labs. Hemodynamic resuscitation strategies studied in randomized trials at National Institutes of Health and Australian and New Zealand Intensive Care Society recommend fluid management and vasopressors such as norepinephrine. Mechanical ventilation practices informed by research at Cleveland Clinic and renal replacement techniques developed at Massachusetts General Hospital address organ support. Adjunctive therapies—corticosteroids, immunoglobulins, and extracorporeal blood purification—have been evaluated in multicenter trials coordinated by institutions including Erasmus University Medical Center and University of Washington.

Prognosis and Outcomes

Outcomes range from full recovery to death, with mortality influenced by timeliness of care, comorbidity burden, and healthcare access. Large cohort analyses published in The Lancet, JAMA, and New England Journal of Medicine quantify mortality trends and long-term sequelae such as post-intensive care syndrome studied at Mayo Clinic and Duke University Hospital. Survivors often experience physical, cognitive, and psychological impairments followed in programs like those at Johns Hopkins Hospital and King's College Hospital. Global outcome improvement initiatives involve collaborations among World Health Organization, Bill & Melinda Gates Foundation, and academic consortia across Harvard Medical School and University of Oxford.

Category:Medical conditions